Momenta (MNTA) Shares Surge 12 percent

April 16, 2015 4:52 PM

1 0

Momenta Pharmaceuticals, Inc. (MNTA) stock is exploding higher by more than 12% Thursday after the company announced that the FDA granted approval of ANDA for Glatopa(TM) (glatiramer acetate injection), the first substitutable generic for COPAXONE(R) (glatiramer acetate injection) 20mg.

“We are proud to be able to offer patients with multiple sclerosis the first generic version of daily COPAXONE and the first generic product in this space,” said in a statement Craig Wheeler, President and CEO, Momenta Pharmaceuticals. “The FDA approval of the ANDA for once daily Glatopa further val...

Also read: BAT offers to buy U.S. tobacco firm Reynolds in $47 billion deal

Read more

To category page